Envestnet Asset Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
61,657
+14,737
+31% +$347K ﹤0.01% 3323
2026
Q1
$702K Buy
46,920
+22,725
+94% +$388K ﹤0.01% 3691
2025
Q4
$352K Sell
24,195
-29,063
-55% -$507K ﹤0.01% 3921
2025
Q3
$955K Buy
53,258
+1,719
+3% +$25.2K ﹤0.01% 3344
2025
Q2
$880K Sell
51,539
-89,860
-64% -$899K ﹤0.01% 3350
2025
Q1
$1.02M Buy
141,399
+19,898
+16% +$226K ﹤0.01% 3188
2024
Q4
$1.71M Buy
+121,501
New +$1.79M ﹤0.01% 2801

Other funds holding CORZ

Envestnet Asset Management's CORZ Position: Q2 2026 in Review

Envestnet Asset Management increased its Core Scientific (CORZ) stake by 31% in Q2 2026, buying an estimated $347K and bringing the position to 61,657 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3323.

Envestnet Asset Management first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.71M in Q4 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Envestnet Asset Management held 61,657 shares of Core Scientific worth $1.58M as of Q2 2026.
  • Envestnet Asset Management bought 14,737 Core Scientific shares in Q2 2026, an estimated $347K.
  • Core Scientific made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3323 holding.
  • Envestnet Asset Management first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • Envestnet Asset Management's Core Scientific position peaked at $1.71M in Q4 2024.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.